10x Genomics ROIC
Was ist das ROIC von 10x Genomics?
ROIC von 10x Genomics, Inc. ist -24.95%
Was ist die Definition von ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu 10x Genomics
Was macht 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Unternehmen mit roic ähnlich 10x Genomics
- Mercury Acquisitions Corp hat ROIC von -25.04%
- Hydaway Ventures Corp hat ROIC von -25.02%
- CleanSpace hat ROIC von -24.99%
- Archos S.A hat ROIC von -24.97%
- RCI Industries & Technologies hat ROIC von -24.97%
- Plug Power Inc hat ROIC von -24.96%
- 10x Genomics hat ROIC von -24.95%
- Kymera Therapeutics hat ROIC von -24.90%
- Ameri Inc hat ROIC von -24.88%
- Pantera Minerals Ltd hat ROIC von -24.86%
- APi hat ROIC von -24.84%
- Sterling and Wilson Solar hat ROIC von -24.84%
- Ardelyx Inc hat ROIC von -24.84%